000 | 01789 a2200577 4500 | ||
---|---|---|---|
005 | 20250518070443.0 | ||
264 | 0 | _c20210727 | |
008 | 202107s 0 0 eng d | ||
022 | _a1757-4684 | ||
024 | 7 |
_a10.15252/emmm.201910880 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeo, Jinbeom | |
245 | 0 | 0 |
_aPhosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis. _h[electronic resource] |
260 |
_bEMBO molecular medicine _c01 2020 |
||
300 |
_ae10880 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCDC2 Protein Kinase _xmetabolism |
650 | 0 | 4 | _aCarcinogenesis |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 |
_aEmbryonic Stem Cells _xcytology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aRepressor Proteins _xmetabolism |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aUrinary Bladder _xpathology |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xpathology |
700 | 1 | _aNoh, Byeong-Joo | |
700 | 1 | _aLee, Seungun | |
700 | 1 | _aLee, Hye-Yeon | |
700 | 1 | _aKim, YongHwan | |
700 | 1 | _aLim, Jisun | |
700 | 1 | _aJu, Hyein | |
700 | 1 | _aYu, Hwan Yeul | |
700 | 1 | _aRyu, Chae-Min | |
700 | 1 | _aLee, Peter Cw | |
700 | 1 | _aJeong, Hwangkyo | |
700 | 1 | _aOh, Yumi | |
700 | 1 | _aKim, Kyunggon | |
700 | 1 | _aKim, Sang-Yeob | |
700 | 1 | _aSon, Jaekyoung | |
700 | 1 | _aHong, Bumsik | |
700 | 1 | _aKim, Jong Soo | |
700 | 1 | _aCho, Yong Mee | |
700 | 1 | _aShin, Dong-Myung | |
773 | 0 |
_tEMBO molecular medicine _gvol. 12 _gno. 1 _gp. e10880 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.15252/emmm.201910880 _zAvailable from publisher's website |
999 |
_c30295953 _d30295953 |